FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2025. Second Quarter Results Net sales for the quarter ended June 30, 2025 were $25.7 million, as compared to $27.7 million for the same period in 2024, a decrease of $2.1 million, or 7.4%. On a Constant dollar basis (see Non-GAAP Measures, b
Related Questions
What impact does the sales decrease have on the company's gross margin and operating expenses?
How does the constantâdollar net sales performance compare to the previous quarter and to peer companies in the healthâwellness sector?
What is the effect of the Q2 results on Mannatech's cash flow, liquidity, and balance sheet metrics?
Did the company provide any updates on forwardâlooking guidance, such as EPS forecasts or capital allocation plans?
How might the earnings miss influence the stock's price action and trading volume in the short term?
What are the potential longâterm implications for the company's market share and competitive positioning?
Are there any macroâeconomic or regulatory factors cited that could be influencing the sales decline and that traders should monitor?
Are there any upcoming product launches or initiatives that could offset the current sales shortfall?
What is the primary driver behind the 7.4% decline in net sales versus Q2 2024?
Has Mannatech revised its revenue guidance for the full year 2025 in light of the Q2 results?